Showing results (181-190 of 227) with videos related to

Sort By:
Pageof 23
Experimental and Molecular Pathology|September 28, 2011
Adiponectin reduces connective tissue growth factor in human hepatocytes which is already induced in non-fibrotic non-alcoholic steatohepatitisRoland Walter, Josef Wanninger, Sabrina Bauer, et al.
Biochimica Et Biophysica Acta|November 13, 2010
Lipid accumulation impairs adiponectin-mediated induction of activin A by increasing TGFbeta in primary human hepatocytesJosef Wanninger, Markus Neumeier, Claus Hellerbrand, et al.
Cytokine|July 20, 2010
Impaired hepatic removal of interleukin-6 in patients with liver cirrhosisReiner Wiest, Johanna Weigert, Josef Wanninger, et al.
The American Journal of Gastroenterology|January 20, 2011
Admission visfatin levels predict pancreatic and peripancreatic necrosis in acute pancreatitis and correlate with clinical severityAndreas Schäffler, Okka-Wilkea Hamer, Judith Dickopf, et al.
World Journal of Gastroenterology|September 29, 2006
Adiponectin and its receptors in rodent models of fatty liver disease and liver cirrhosisMarkus Neumeier, Claus Hellerbrand, Erwin Gäbele, et al.
Lipids in Health and Disease|October 3, 2023
Fecal short chain fatty acids and urinary 3-indoxyl sulfate do not discriminate between patients with Crohn´s disease and ulcerative colitis and are not of diagnostic utility for predicting disease severityHauke Christian Tews, Tanja Elger, Stefan Gunawan, et al.
American Journal of Physiology. Gastrointestinal and Liver Physiology|July 18, 2009
Adiponectin-stimulated CXCL8 release in primary human hepatocytes is regulated by ERK1/ERK2, p38 MAPK, NF-kappaB, and STAT3 signaling pathwaysJosef Wanninger, Markus Neumeier, Johanna Weigert, et al.
The Journal of Clinical Endocrinology and Metabolism|January 19, 2010
Serum galectin-3 is elevated in obesity and negatively correlates with glycosylated hemoglobin in type 2 diabetesJohanna Weigert, Markus Neumeier, Josef Wanninger, et al.
International Journal of Molecular Sciences|January 8, 2020
Overexpression of Hepatocyte Chemerin-156 Lowers Tumor Burden in a Murine Model of Diethylnitrosamine-Induced Hepatocellular CarcinomaElisabeth M Haberl, Rebekka Pohl, Lisa Rein-Fischboeck, et al.
Biomedicines|January 21, 2022
Chemerin Overexpression in the Liver Protects against Inflammation in Experimental Non-Alcoholic SteatohepatitisRebekka Pohl, Susanne Feder, Elisabeth M Haberl, et al.
Pageof 23